grant

Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 3 Jun 2023Deadline 31 May 2028
NIHUS FederalResearch GrantFY20252-photon microscopyAddressAgeAgingAnimalsApoplexyArteriesAutoregulationBBB penetrationBlood VesselsBrain TIABrain VascularBrain Vascular AccidentCGRP ReceptorsCalcitonin Gene-Related PeptideCalcitonin-Gene Related Peptide ReceptorCardiac infarctionCase StudyCerebral IschemiaCerebral StrokeCerebrovascular ApoplexyCerebrovascular CirculationCerebrovascular StrokeCerebrumChronicClassic MigraineClassical MigraineClinical Treatment MoabClinical TrialsCommon Rat StrainsConflict of InterestDataDefectDiabetes MellitusDistalDoppler OCTDoseDrug IndustryDrugsDysfunctionEventExclusionFamilial Hemiplegic MigraineFemaleFlowmetryFunctional disorderFundingFutureGoalsHandHomeostasisHypertensionImaging DeviceImaging InstrumentImaging ToolImpairmentIndustryInfarctionIschemiaIschemic StrokeKI miceKnock-in MouseLaboratoriesLaser ElectromagneticLaser RadiationLasersMR ImagingMR TomographyMRIMRIsMagnetic Resonance ImagingMediatingMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMedicationMethodsMiceMice MammalsMiddle Cerebral Artery OcclusionMigraineMigraine HeadacheMigraine with AuraMigraine with Typical AuraMissionModelingMonoclonal AntibodiesMurineMusMyocardial InfarctMyocardial InfarctionNMR ImagingNMR TomographyNational Institutes of HealthNeurologic DeficitNuclear Magnetic Resonance ImagingOCT TomographyOptical Coherence TomographyOutcomePatientsPenetrationPerfusionPharmaceutic IndustryPharmaceutical IndustryPharmaceutical PreparationsPhysiological HomeostasisPhysiopathologyPositionPositioning AttributePreclinical dataProphylactic treatmentProphylaxisRatRats MammalsRattusReportingReproducibilityResearchRiskRisk FactorsSafetyStrokeStructureTarget PopulationsTestingTherapeuticTransient Ischemic AttackTrustUnited States National Institutes of HealthVascular Hypertensive DiseaseVascular Hypertensive DisorderVasodilatationVasodilating AgentVasodilationVasodilator AgentsVasodilator DrugsVasodilatorsVasorelaxationWorkZeugmatographyagedagesantagonismantagonistarmblood flow in brainblood-brain barrier penetrationbloodbrain barrier penetrationbrain attackbrain blood circulationbrain blood flowcardiac infarctcase reportcerebralcerebral blood flowcerebral circulationcerebral vascularcerebral vascular accidentcerebro-vascularcerebrocirculationcerebrovascularcerebrovascular accidentcerebrovascular blood flowcerebrovascular imagingclinical developmentco-morbidco-morbiditycomorbiditycoronary attackcoronary infarctcoronary infarctiondiabetesdiabeticdrug/agentexperimentexperimental researchexperimental studyexperimentshandsheart attackheart infarctheart infarctionhigh blood pressurehyperpiesiahyperpiesishypertensivehypertensive diseasehypertensive disorderin vivoinfarctknockin micelight scatteringmAbsmalemigraine therapymigraine treatmentmini strokemini-strokemonoclonal Absmortalitynoveloptic imagingoptical Doppler tomographyoptical coherence Doppler tomographyoptical imagingoptogeneticspathophysiologypatient populationpreclinical findingspreclinical informationresponserisk mitigationsmall moleculespreading depressionstrokedstrokestwo photon excitation microscopytwo photon microscopyvascularvascular risk factor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Small molecule calcitonin gene-related peptide (CGRP) receptor antagonists (“gepants”) and anti-CGRP or anti-
CGRP-receptor monoclonal antibodies (“nezumabs”) are novel treatments for migraine. However, endogenous

CGRP is among the most potent vasodilator molecules, and CGRP-mediated vasodilation is a critical rescue

mechanism in cerebral…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Safety of Anti-CGRP Migraine Therapeutics in Ischemic Stroke — MASSACHUSETTS GENERAL HOSPITAL | UNITED STATES | Jun 2023 | Dev Procure